Open Forum Infectious Diseases

OFID is seeking research on expanding diagnostic, preventative, and therapeutic strategies to counter the impacts of AMR with a focus in low and middle income countries. Learn more and submit a proposal by June 28: bit.ly/3OGh1l1

Outcome of and risk factors for mortality in pediatric COVID-19 encephalitis during the 2022 Omicron wave in Taiwan: a national retrospective study ✅ Just Accepted 🔗 bit.ly/4slnxMK

Comparison of six weeks doxycycline versus six weeks rifampicin or three weeks of the combination of doxycycline plus rifampicin in the treatment of onchocerciasis: a randomized, placebo-controlled, double-blind, phase 2 trial ✅ Just Accepted 🔗 bit.ly/3NMnUkr

Cutaneous Larva Migrans Within the United States Military Health System – Clinical Presentation and Association with Autochthonous Spread or International Travel ✅ Just Accepted 🔗 bit.ly/4uBFBnv

Re-evaluating the Potential Impact of PrEP in Achieving HIV Elimination in the United States: Insights from Modeling ✅ Just Accepted 🔗 bit.ly/3Ph55Gu

Implementation of an early transition to oral antibiotics for patients with non-staphylococcal bacteremia via real-time stewardship intervention ✅ Just Accepted 🔗 bit.ly/4bAvman

Rounding Styles on Inpatient Infectious Disease Consult Services: Impact on Education and Patient-Care Delivery ✅ Just Accepted 🔗 bit.ly/4lBBkfJ

Emphasizing the O in OPAT: A pathway for clinic-initiated outpatient parenteral antimicrobial therapy (CI-OPAT) at an academic center ✅ Just Accepted 🔗 bit.ly/3P8NII1

Targeted Genomic Surveillance Unveils Genetic Variations linked to Regional Malaria Drug Resistance Dynamics in India ✅ Just Accepted 🔗 bit.ly/4urRagT

Population-Based Study of Carbapenem-Resistant Raoultella spp. Reveals Diverse Repertoire of Carbapenemase Genes ✅ Just Accepted 🔗 bit.ly/4705xir

Penicillin Allergy Labels and High-Risk Antibiotic Prescribing Among Incarcerated Individuals Receiving Antibiotics Across Four U.S. Carceral Systems ✅ Just Accepted 🔗 bit.ly/4bjud6Q

Respiratory virus co-infection is a risk factor for adverse outcomes during Staphylococcus aureus bacteraemia ✅ Just Accepted 🔗 bit.ly/4cHhrS3

Antimicrobial Pharmacokinetic and Pharmacodynamic Considerations in Special Populations: A Call to Action ✅ Just Accepted 🔗 bit.ly/4bmU8ux

Association between Low-dose Ethambutol Therapy and Optic Neuropathy in Mycobacterium avium Complex Pulmonary Disease: A Retrospective Cohort Study Using Propensity Score Analysis ✅ Just Accepted 🔗 bit.ly/40zpKbg

Toxoplasmosis acquired in French Guiana in immunocompetent adults: case series from 2002 to 2019, with a focus on outpatients ✅ Just Accepted 🔗 bit.ly/3P8NGje

Intravenous immunoglobulin treatment in patients with streptococcal toxic shock syndrome in southern Sweden – A retrospective population-based study ✅ Just Accepted 🔗 bit.ly/4lpCNFL

Comparing Efficacy and Safety of Itraconazole Solution versus Posaconazole for Antifungal Prophylaxis after Heart Transplant ✅ Just Accepted 🔗 bit.ly/4bkq6rd

Liver Necrosis in a Patient Receiving Isavuconazole: Making the Case for Therapeutic Drug Monitoring ✅ Just Accepted 🔗 bit.ly/4rumNnb

Underrated, Unvaccinated, Untreated: A Multinational Registry Analysis of Hmpv in Haematological Malignancy, Insights From EpiCOVIDeha/Epiresha Registry ✅ Just Accepted 🔗 bit.ly/3PsiOdw

Use of DOOR and Win-Ratio Analysis in a Secondary Evaluation of a Histoplasmosis Clinical Trial ✅ Just Accepted 🔗 bit.ly/4cYsIO7